Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.4626
+0.0018 (0.39%)
At close: May 26, 2026, 4:00 PM EDT
0.4620
-0.0006 (-0.13%)
After-hours: May 26, 2026, 7:41 PM EDT

Cytosorbents Revenue

Cytosorbents had revenue of $8.86M in the quarter ending March 31, 2026, with 1.57% growth. This brings the company's revenue in the last twelve months to $19.10M, up 9.44% year-over-year. In the year 2025, Cytosorbents had annual revenue of $37.06M with 4.12% growth.

Revenue (ttm)
$19.10M
Revenue Growth
+9.44%
P/S Ratio
0.81
Revenue / Employee
$288,372
Employees
129
Market Cap
29.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202537.06M1.47M4.12%
Dec 31, 202435.60M4.51M14.51%
Dec 31, 202331.09M-3.60M-10.39%
Dec 31, 202234.69M-8.48M-19.64%
Dec 31, 202143.17M2.16M5.27%
Dec 31, 202041.00M16.06M64.35%
Dec 31, 201924.95M2.45M10.87%
Dec 31, 201822.50M7.35M48.53%
Dec 31, 201715.15M5.62M59.02%
Dec 31, 20169.53M4.74M98.84%
Dec 31, 20154.79M668.79K16.22%
Dec 31, 20144.12M1.70M70.18%
Dec 31, 20132.42M1.08M80.40%
Dec 31, 20121.34M1.31M3,622.32%
Dec 31, 201136.08K--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray428.57M
Nortech Systems121.79M
TELA Bio80.81M
Myomo41.21M
Lifeward20.92M
NeuroOne Medical Technologies12.72M
Pulsenmore12.55M
IceCure Medical3.57M
Revenue Rankings